Dr. Jennifer Leiding is an Associate Professor in the Division of Allergy and Immunology, Department of Pediatrics at Johns Hopkins University. She is the Associate Director of the Institute for Clinical and Translational Research and the Associate Director of the Center for Cell and Gene Therapy at Johns Hopkins All Children's Hospital . After completing medical school and pediatric residency at the University of South Florida, she went on to complete allergy and immunology fellowship at the National Institute of Allergy and Infectious Diseases and post-doctoral research in the Laboratory of Clinical Infectious Diseases at NIAID.

Her clinical expertise is in the diagnosis and treatment inborn errors of immunity and immunodysregulation.  She is the lead investigator for Primary Immunodeficiency Treatment Consortium Protocol 6908 which aims to understand the treatment of Chronic Granulomatous Disease. She also has precision-based therapy and bone marrow transplatn for patients with STAT1 and STAT3 gain of function. Dr. Leiding’s research interests include investigating the mechanisms of inflammatory disease in chronic granulomatous disease and other primary immunodysregulatory diseases.